Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients with type 2 diabetes than using GLP-1 receptor agonists, a study finds.
US Trade Representative Jamieson Greer on Tuesday said he is open to treating South Africa differently than other African ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback